Skip to main content

Xovoltib 20mg tablet| Afatinib Uses & Side effects

XOVOLTIB 20MG

DESCRIPTION

This is a phase 2 study that examines the performance of a targeted cancer drug known as Xovoltib 20mg .
Xovoltib 20mg  Tablets  prohibit EGFR protein, which accepts to be included in the growth management of chordoma tumors.
This study is planned especially for chordoma patients 18 years of age or older, with recurrent or metastatic tumors.
Xovoltib 20 mg which is used as a prescription drug under the guidance of the oncologist.

INDICATION

Xovoltib 20mg  Tablets  are used for first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC)

MECHANISM OF ACTION

The Afatinib mechanism by preventing the activity of a group of proteins known as epidermal growth factor receptors (EGFRs). The epidermal growth factor receptor is a protein that is included in the growth and spread of cancer cells; Afatinib works by inhibiting the action of this protein.
Afatinib should not be taken by people who have EGFR-negative tumors.

PRODUCT DETAILS

Brand: Xovoltib
Ingrediente: Afatinib
Forța: 20mg
Manufactured: GSK pharmaceutical products
Package: 7 tablets in one tape
 20mg

20mg

pharmacokinetics

• The maximum plasma time is 2-5 hours and the bioavailability is 92%
• Human plasma protein bound is 95%
• The main circulating metabolites are covalent adducts to proteins.
• Excretion of fecal drugs is 85% and urine 4%.

DOSAGE MANAGEMENT

For adults: 40 mg given once daily is the prescribed dose for adult patients with metastatic small cell lung cancer. The age of 0-17 years is not prescribed in children.
Avoid using Xovoltib 20 mg tablets under 18 years of age
The prescribed dose for renal failure is given 30 mg once daily
Administration:
The medicine Xovoltib 20 mg on an empty stomach.
Take Xovoltib 20 mg tablets one hour before or 2 hours after a meal
Avoid cutting or crushing the tablet
Overdose: Overdose is related to patients who have been given 360 mg of Xovoltib 20mg, which causes nausea, vomiting, asthenia, abdominal pain and, consequently, has offered supportive measures for recovery.

PRECAUTIONS

Severe dehydration may occur with the use of  Xovoltib 20mg  Tablets  . This can lead to severe or persistent diarrhea, vomiting or reduced fluid intake. Dehydration can lead to kidney failure, if severe enough. During treatment with this medicine, you may be encouraged to drink additional water.
During treatment with Xovoltib, 20 mg will result in hepatotoxicity; monitor with regular liver testing; Withholding or stopping treatment for severe or worsening liver tests
The drug can lead to interstitial lung disease (ILD)
When given to pregnant women,  Xovoltib 20mg  Tablets  will have fetal wounds (embryo-fetal toxicity)
Discontinue if patients confirm with suspected keratitis or ulcerative keratitis
With Xovoltib 20mg increased sunburn / phototoxicity; it can aggravate the rash or acne; Patients use caution to limit sun exposure and if sun protection and protective clothing.
Sometimes  Xovoltib 20mg  Tablets  have been linked to corneal perforation, a serious injury to the part of the eye that is easily concentrated in the eye. If you have persistent eye pain or vision changes, inform your doctor immediately.

Image result for non-small cell lung cancer
 Small cell lung cancer (NSCLC)

SIDE EFFECTS

Common side effects caused:
• Mild diarrhea for 1 day or less
• Decreased appetite
• Nausea and vomiting
• Oral ulcer
• Acne, itching, dry skin
• Red color, tenderness, swelling or other signs of infection around the nails or nails
Reacții adverse grave:
• Eye problems - blurred vision, watery eyes, increased light sensitivity
• Liver problems - stomach pain, sensation, dark urine
• Heart problems
• The color of the urine changes to dark
• Bleeding or bruising
• Weakness
• Blurry vision
• Fast heartbeat
• Breathing problems
• Cough and fever
• Yellowing of the skin

DRUG INTERACTION

Co-administration of Xovoltib 20 mg with P-gp inhibitors (cyclosporine A, ketoconazole verapamil) will have a high exposure to Afatinib
When Xovoltib 20mg interaction  Tablets  with P-gp inducers (carbamazepine, phenytoin, phenobarbital) will decrease exposure to Afatinib 

The dosage taken

If the patient missed the dose of Xovoltib 20mg , then the missed dose should be skipped and follow the regular administration schedule. Do not take the double dose Consult your doctor and follow the suggestions.

PREGNANCY

Pregnancy category: c
During treatment with  Xovoltib 20mg  Tablets  Pregnancy should be avoided because the drug 
Xovoltib 20 mg is given to a pregnant woman who will harm the fetus.

breastfeeding

Xovoltib 20mg  Tablets  Excretion in human milk is not known or will have an adverse reaction in a breast-feeding child. Therefore, the decision can be made if you stop breastfeeding or discontinuing the drug.

STORAGE

• Xovoltib 20mg Comprimatela 25 ° C
• Take  Xovoltib 20mg  Tablets  for children
• Protect from moisture and light.

CONTACT US 

ID EMAIL:  millionhealthpharmaceuticals@gmail.com

TELEPHONE NR:  + 91-9940472902

Comments

  1. hi dear, thanks for share a such a beautiful information about Xovoltib 20mg tablet.


    Afatinib 40 mg

    ReplyDelete

Post a Comment

Popular posts from this blog

Купи Revolade 25mg| Цена Revolade 25mg продукт

REVOLADE  25мг ОПИСАНИЕ Eltrombopag се продава под търговската марка Revolade и е изкуствена форма на протеин, който увеличава производството на тромбоцити (кръвосъсирващи клетки) в тялото ви. Revolade 25мг може да намали риска от кървене чрез увеличаване на тромбоцитите в кръвта. Revolade 25мг капсулы , който се използва като лекарство за предписване под ръководството на медицинските специалисти ПОКАЗАНИЯ Revolade 25 мг е противораково лекарство, което е; Показани за лечение на пациенти с тежка апластична анемия • Първа линия на лечение на тежка апластична анемия • Лечение на рефрактерна тежка апластична анемия Посочени за лечение, за стимулиране на растежа и развитието на тромбоцити в костния мозък Показано е предимно за лечение на пациенти с намален брой тромбоцити поради хронична инфекция с вируса на хепатит С МЕХАНИЗЪМ НА ДЕЙСТВИЕ Елтромбопаг се състои от клас лекарства, известни като агонисти на тромбопоетиновите рецептори. Клас лекарства е група лекарства...

Prolia 60mg injection | Denosumab | MHP

PROLIA 60MG DESCRIPTION: Prolia 60mg  is a human monoclonal antibody for the treatment of osteoporosis, treatment-persuaded bone loss, metastases to bone, and giant cell tumor of bone. Prolia 60mg contraindicated in people with low blood calcium levels. Prolia 60mg injection is prescription drug which is used under the guidance of medical oncologist. INDICATION: • Indicated for treatment of osteoporosis at high risk postmenopausal women with (end of menopause/ change of life), whose have serious problem of fractures raised or who failed to other medication of osteoporosis. • Indicated for treatment of Breast cancer in women whose taking certain treatment which make severe their risk of fractures and bone loss in men with prostate cancer. • Indicated for treatment in adults and some adolescents with giant cell tumor of bone which cannot treat with surgery / surgery is not possible is treated with Prolia 60mg injection . MECHANISM OF ACTION: Denosumab mechanism by aim...

sovihep D

sovihep D Description The active substance is Sofosbuvir and Daclatasvir ( sovihep d tablet ), which is an inhibitor of the NS5A protein required for the synthesis of HCV. The main purpose of the  sovihep d  is antiviral therapy. It is active in the fight against viral hepatitis C (genotypes 1, 2, 3, 4). The essence of the impact is to block the development of HCV and its spread in the body of the carrier. HCV exists in different forms known as genotypes. Genotype 1 is the most common type of HCV genotype and  sovihep d tablet  is also the most difficult to treat using other treatments. Mechanism of Action: DCV is an HCV NS5A replication complex inhibitor. This NS5A  sovihep d  viral protein has enzymatic activity that is essential for HCV RNA replication and assembly. In replication it appears to play a role in the formation of a membranous web along with viral protein NS4B, and this web provides a platform for replication. The NS5A protein is compo...